img

Global Niergoline Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 411 | Industry : Pharma & Healthcare

Publisher : GRD Survey | Format : PDF

Global Niergoline Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Niergoline market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.

This report studies the Niergoline market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Niergoline in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
For Injection
For Oral

Market Snapshot, By Application
Alzheimer's Disease (AD)
Arterial Hypertension
Cerebral Thrombosis
Others

Main Market Players Analyzed in this report, including
Tocris Bioscience
Teva API
Solarium Pharmaceuticals
Selleck Chemicals
Pfizer Pharmaceutical Co., Ltd.
olon
LGC
Hebei Lingding Biotechnology Co., Ltd.
Hainan Poly Pharm Co. Ltd
Fengchen
FAREVA
DEAFARMA

The study objectives of this report are
To study and analyze the global Niergoline market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Niergoline market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Niergoline manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Niergoline market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Niergoline submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Niergoline are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Global Niergoline Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028.pdf

List of Figure

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Niergoline Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Niergoline Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Niergoline

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Niergoline Sales Channel and Distributors Analysis
3.3.1 Niergoline Sales Channel
3.3.2 Niergoline Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Alzheimer's Disease (AD)
3.4.2 Major Buyers in Arterial Hypertension
3.5 Niergoline Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Niergoline Type Introduction
4.1.1 For Injection
4.1.2 For Oral
4.2 Global Niergoline Sales by Type 2016-2021
4.3 Global Niergoline Revenue by Type 2016-2021
4.4 Global Niergoline Price by Type 2016-2021

5 Market Segment: by Application
5.1 Niergoline Type Introduction
5.1.1 Alzheimer's Disease (AD)
5.1.2 Arterial Hypertension
5.1.3 Cerebral Thrombosis
5.1.3 Others
5.2 Global Niergoline Sales by Application 2016-2021
5.3 Global Niergoline Revenue by Application 2016-2021
5.4 Global Niergoline Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Niergoline Market by Region
6.1.1 Global Niergoline Sales by Regions
6.1.2 Global Niergoline Revenue by Regions
6.2 North America Niergoline Market 2016-2021
6.3 Europe Niergoline Market 2016-2021
6.4 Asia Pacific Niergoline Market 2016-2021
6.5 South America Niergoline Market 2016-2021
6.6 Middle East and Africa Niergoline Market 2016-2021

7 North America
7.1 North America Niergoline Market by Country 2016-2021
7.1.1 North America Niergoline Sales by Country
7.1.2 North America Niergoline Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Niergoline Market by Country 2016-2021
8.1.1 Europe Niergoline Sales by Country
8.1.2 Europe Niergoline Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Niergoline Market by Country 2016-2021
9.1.1 Asia Pacific Niergoline Sales by Country
9.1.2 Asia Pacific Niergoline Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Niergoline Market by Country 2016-2021
10.1.1 South America Niergoline Sales by Country
10.1.2 South America Niergoline Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Niergoline Market by Country 2016-2021
11.1.1 Middle East and Africa Niergoline Sales by Country
11.1.2 Middle East and Africa Niergoline Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Tocris Bioscience
12.1.1 Tocris Bioscience Company Information
12.1.2 Tocris Bioscience Niergoline Product Portfolio, Specification and Application
12.1.3 Tocris Bioscience Niergoline Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Tocris Bioscience Key Development
12.2 Teva API
12.2.1 Teva API Company Information
12.2.2 Teva API Niergoline Product Portfolio, Specification and Application
12.2.3 Teva API Niergoline Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Teva API Key Development
12.3 Solarium Pharmaceuticals
12.3.1 Solarium Pharmaceuticals Company Information
12.3.2 Solarium Pharmaceuticals Niergoline Product Portfolio, Specification and Application
12.3.3 Solarium Pharmaceuticals Niergoline Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Solarium Pharmaceuticals Key Development
12.4 Selleck Chemicals
12.4.1 Selleck Chemicals Company Information
12.4.2 Selleck Chemicals Niergoline Product Portfolio, Specification and Application
12.4.3 Selleck Chemicals Niergoline Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Selleck Chemicals Key Development
12.5 Pfizer Pharmaceutical Co., Ltd.
12.5.1 Pfizer Pharmaceutical Co., Ltd. Company Information
12.5.2 Pfizer Pharmaceutical Co., Ltd. Niergoline Product Portfolio, Specification and Application
12.5.3 Pfizer Pharmaceutical Co., Ltd. Niergoline Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Pfizer Pharmaceutical Co., Ltd. Key Development
12.6 olon
12.6.1 olon Company Information
12.6.2 olon Niergoline Product Portfolio, Specification and Application
12.6.3 olon Niergoline Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 olon Key Development
12.7 LGC
12.7.1 LGC Company Information
12.7.2 LGC Niergoline Product Portfolio, Specification and Application
12.7.3 LGC Niergoline Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 olon Key Development
12.9 Hainan Poly Pharm Co. Ltd
12.9.1 Hainan Poly Pharm Co. Ltd Company Information
12.9.2 Hainan Poly Pharm Co. Ltd Niergoline Product Portfolio, Specification and Application
12.9.3 Hainan Poly Pharm Co. Ltd Niergoline Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Hainan Poly Pharm Co. Ltd Key Development
12.8 Hebei Lingding Biotechnology Co., Ltd.
12.8.1 Hebei Lingding Biotechnology Co., Ltd. Company Information
12.8.2 Hebei Lingding Biotechnology Co., Ltd. Niergoline Product Portfolio, Specification and Application
12.8.3 Hebei Lingding Biotechnology Co., Ltd. Niergoline Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Hebei Lingding Biotechnology Co., Ltd. Key Development
12.11 FAREVA
12.11.1 FAREVA Company Information
12.11.2 FAREVA Niergoline Product Portfolio, Specification and Application
12.11.3 FAREVA Niergoline Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 FAREVA Key Development
12.12 DEAFARMA
12.12.1 DEAFARMA Company Information
12.12.2 DEAFARMA Niergoline Product Portfolio, Specification and Application
12.12.3 DEAFARMA Niergoline Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 DEAFARMA Key Development

13 Global Niergoline Market Forecast by Region by Type and by Application
13.1 Global Niergoline Sales, Revenue Forecast 2022-2027
13.2 Global Niergoline Forecast by Regions
13.2.1 Global Niergoline Sales Forecast by Region 2022-2027
13.2.2 Global Niergoline Revenue Forecast by Region 2022-2027
13.3 Global Niergoline Forecast by Type
13.3.1 Global Niergoline Sales Forecast by Type 2022-2027
13.3.2 Global Niergoline Revenue Forecast by Type 2022-2027
13.3.3 Global Niergoline Price Forecast by Type 2022-2027
13.4 Global Niergoline Forecast by Application
13.4.1 Global Niergoline Sales Forecast by Application 2022-2027
13.4.2 Global Niergoline Revenue Forecast by Application 2022-2027
13.4.3 Global Niergoline Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer